86 related articles for article (PubMed ID: 27881238)
1. Rational identification of natural organic compounds to target the intermolecular interaction between Foxm and DNA in colorectal cancer.
Dong C; Yan P; Wang J; Mu H; Wang S; Guo F
Bioorg Chem; 2017 Feb; 70():12-16. PubMed ID: 27881238
[TBL] [Abstract][Full Text] [Related]
2. Integrated discovery of FOXO1-DNA stabilizers from marine natural products to restore chemosensitivity to anti-EGFR-based therapy for metastatic lung cancer.
Sun Y; Ai X; Hou J; Ye X; Liu R; Shen S; Li Z; Lu S
Mol Biosyst; 2017 Jan; 13(2):330-337. PubMed ID: 27966721
[TBL] [Abstract][Full Text] [Related]
3. Conformational stabilization of FOX-DNA complex architecture to sensitize prostate cancer chemotherapy.
Chen B; Wang H; Wu Z; Duan B; Bai P; Zhang K; Li W; Zheng J; Xing J
Amino Acids; 2017 Jul; 49(7):1247-1254. PubMed ID: 28474127
[TBL] [Abstract][Full Text] [Related]
4. Untying the knot of transcription factor druggability: Molecular modeling study of FOXM1 inhibitors.
Tabatabaei-Dakhili SA; Aguayo-Ortiz R; Domínguez L; Velázquez-Martínez CA
J Mol Graph Model; 2018 Mar; 80():197-210. PubMed ID: 29414039
[TBL] [Abstract][Full Text] [Related]
5. Docking studies on DNA intercalators.
Gilad Y; Senderowitz H
J Chem Inf Model; 2014 Jan; 54(1):96-107. PubMed ID: 24303988
[TBL] [Abstract][Full Text] [Related]
6. Molecular dynamics simulation studies for DNA sequence recognition by reactive metabolites of anticancer compounds.
Tumbi KM; Nandekar PP; Shaikh N; Kesharwani SS; Sangamwar AT
J Mol Recognit; 2014 Mar; 27(3):138-50. PubMed ID: 24446378
[TBL] [Abstract][Full Text] [Related]
7. Structural basis of TBX5-DNA recognition: the T-box domain in its DNA-bound and -unbound form.
Stirnimann CU; Ptchelkine D; Grimm C; Müller CW
J Mol Biol; 2010 Jul; 400(1):71-81. PubMed ID: 20450920
[TBL] [Abstract][Full Text] [Related]
8. New design of nucleotide excision repair (NER) inhibitors for combination cancer therapy.
Gentile F; Tuszynski JA; Barakat KH
J Mol Graph Model; 2016 Apr; 65():71-82. PubMed ID: 26939044
[TBL] [Abstract][Full Text] [Related]
9. Computational Identification of Druggable Bioactive Compounds from
Islam MR; Awal MA; Khames A; Abourehab MAS; Samad A; Hassan WMI; Alam R; Osman OI; Nur SM; Molla MHR; Abdulrahman AO; Rajia S; Ahammad F; Hasan MN; Qadri I; Kim B
Molecules; 2022 Mar; 27(7):. PubMed ID: 35408488
[TBL] [Abstract][Full Text] [Related]
10. Overexpressed transcription factor FOXM1 contributes to the progression of colorectal cancer.
Zhang H; Zhong H; Li L; Ji W; Zhang X
Mol Med Rep; 2016 Mar; 13(3):2696-700. PubMed ID: 26861549
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of forkhead box protein M1 (FOXM1) plays a critical role in colorectal cancer.
Zhang HG; Xu XW; Shi XP; Han BW; Li ZH; Ren WH; Chen PJ; Lou YF; Li B; Luo XY
Clin Transl Oncol; 2016 May; 18(5):527-32. PubMed ID: 26370421
[TBL] [Abstract][Full Text] [Related]
12. Comparative docking of dual conformations in human fatty acid synthase thioesterase domain reveals potential binding cavity for virtual screening of ligands.
John A; Vetrivel U; Subramanian K; Deepa PR
J Biomol Struct Dyn; 2017 May; 35(6):1350-1366. PubMed ID: 27145135
[TBL] [Abstract][Full Text] [Related]
13. Probing the structure of Mycobacterium tuberculosis MbtA: model validation using molecular dynamics simulations and docking studies.
Maganti L; Open Source Drug Discovery Consortium ; Ghoshal N
J Biomol Struct Dyn; 2014; 32(2):273-88. PubMed ID: 23527569
[TBL] [Abstract][Full Text] [Related]
14. Protein-DNA interfaces: a molecular dynamics analysis of time-dependent recognition processes for three transcription factors.
Etheve L; Martin J; Lavery R
Nucleic Acids Res; 2016 Nov; 44(20):9990-10002. PubMed ID: 27658967
[TBL] [Abstract][Full Text] [Related]
15. Blocking the interaction between HIV-1 integrase and human LEDGF/p75: mutational studies, virtual screening and molecular dynamics simulations.
Reddy KK; Singh P; Singh SK
Mol Biosyst; 2014 Mar; 10(3):526-36. PubMed ID: 24389668
[TBL] [Abstract][Full Text] [Related]
16. Could the FDA-approved anti-HIV PR inhibitors be promising anticancer agents? An answer from enhanced docking approach and molecular dynamics analyses.
Arodola OA; Soliman ME
Drug Des Devel Ther; 2015; 9():6055-65. PubMed ID: 26622167
[TBL] [Abstract][Full Text] [Related]
17. Rational design of biaryl pharmacophore inserted noscapine derivatives as potent tubulin binding anticancer agents.
Santoshi S; Manchukonda NK; Suri C; Sharma M; Sridhar B; Joseph S; Lopus M; Kantevari S; Baitharu I; Naik PK
J Comput Aided Mol Des; 2015 Mar; 29(3):249-70. PubMed ID: 25481458
[TBL] [Abstract][Full Text] [Related]
18. DNA Interaction Studies and In Vitro Cytotoxicity of Newly Synthesized Steroidal Imidazolidinones.
Dar AM; Gatoo MA; Ahmad A; Ahmad MS; Najar MH; Shamsuzzaman
J Fluoresc; 2015 Sep; 25(5):1377-87. PubMed ID: 26245453
[TBL] [Abstract][Full Text] [Related]
19. Importance of molecular computer modeling in anticancer drug development.
Geromichalos GD
J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
[TBL] [Abstract][Full Text] [Related]
20. Exploring dual inhibitors for STAT1 and STAT5 receptors utilizing virtual screening and dynamics simulation validation.
Raj U; Kumar H; Gupta S; Varadwaj PK
J Biomol Struct Dyn; 2016 Oct; 34(10):2115-29. PubMed ID: 26471877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
